328 related articles for article (PubMed ID: 24117028)
21. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice.
Kamada H; Tsutsumi Y; Yamamoto Y; Kihira T; Kaneda Y; Mu Y; Kodaira H; Tsunoda SI; Nakagawa S; Mayumi T
Cancer Res; 2000 Nov; 60(22):6416-20. PubMed ID: 11103807
[TBL] [Abstract][Full Text] [Related]
22. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
[TBL] [Abstract][Full Text] [Related]
23. Phenformin-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo.
Krishnamurthy S; Ng VW; Gao S; Tan MH; Yang YY
Biomaterials; 2014 Nov; 35(33):9177-86. PubMed ID: 25106770
[TBL] [Abstract][Full Text] [Related]
24. The in vitro and in vivo anti-tumor effects of MTX-Fe3O 4-PLLA-PEG-PLLA microspheres prepared by suspension-enhanced dispersion by supercritical CO2.
Chen A; Dang T; Wang S; Tang N; Liu Y; Wu W
Sci China Life Sci; 2014 Jul; 57(7):698-709. PubMed ID: 24935781
[TBL] [Abstract][Full Text] [Related]
25. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.
Chen Q; Millar HJ; McCabe FL; Manning CD; Steeves R; Lai K; Kellogg B; Lutz RJ; Trikha M; Nakada MT; Anderson GM
Clin Cancer Res; 2007 Jun; 13(12):3689-95. PubMed ID: 17575234
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
[TBL] [Abstract][Full Text] [Related]
27. A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma.
Wang JL; Tang GP; Shen J; Hu QL; Xu FJ; Wang QQ; Li ZH; Yang WT
Biomaterials; 2012 Jun; 33(18):4597-607. PubMed ID: 22469295
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
29. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
30. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
31. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
32. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
33. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's disease fistulae.
Foong KS; Patel R; Forbes A; Day RM
Tissue Eng Part C Methods; 2010 Oct; 16(5):855-64. PubMed ID: 19886803
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
[TBL] [Abstract][Full Text] [Related]
36. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
[TBL] [Abstract][Full Text] [Related]
37. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
38. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
39. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
40. Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity.
Chen L; Liu YH; Li YH; Jiang Y; Xie PL; Zhou GH; Li GC
Int Immunopharmacol; 2014 Jan; 18(1):20-6. PubMed ID: 24239629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
